IP Library Granted Patent US 12,478,453
Granted Patent B2
US 12,478,453 · App. 17/999,983 · Granted Nov 25, 2025

Presentation of patient information for cardiac blood flow procedures

Inventors: Peter N. Braido (Linwood, MN); Mina S. Fahim (New Brighton, MN); Ross D. Hinrichsen (Minneapolis, MN); Shinichi Joseph Takayama (Shoreview, MN)
Assignee: MEDTRONIC, INC.
A61B90/361A61B5/0035A61B5/0044A61B5/068A61B18/1492A61B34/10A61B34/20A61B34/30G06T19/006G16H30/20A61B5/0036A61B2034/102A61B2034/105A61B2034/2046A61B2090/365
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,453
App. No.
17/999,983
Granted
Nov 25, 2025
Kind
B2
Abstract

Novel tools and techniques are provided for presenting patient information to a user. In some embodiments, a computer system may: receive device data associated with one or more devices configured to perform a cardiac blood flow procedure to provide effective blood flow through a heart and to or from blood vessels of a patient; receive one or more imaging data associated with one or more imaging devices configured to generate images of one or more internal portions of the patient; analyze the device data and the imaging data; map the device data and the imaging data to a multi-dimensional representation of the one or more internal portions of the patient; generate one or more image-based outputs based at least in part on the mapping; and present, using a user experience (“UX”) device, the generated one or more image-based outputs.

Claims (62)

1 . A method for presenting patient information to a user, the method comprising:

receiving, with a computing system, one or more device data associated with each of one or more devices configured to perform a cardiac blood flow procedure to provide effective blood flow through a heart and to or from blood vessels of a patient;

receiving, with the computing system, one or more imaging data associated with each of one or more imaging devices configured to generate images of one or more internal portions of the patient;

analyzing, with the computing system, the received one or more device data and the received one or more imaging data;

mapping, with the computing system, the received one or more device data and the received one or more imaging data to a multi-dimensional representation of the one or more internal portions of the patient, based at least in part on the analysis, wherein the multi-dimensional representation comprises data corresponding to three dimensions, four dimensions, or more than four dimensions;

generating, with the computing system, one or more extended reality (“XR”) experiences based at least in part on the mapping, wherein the one or more XR experiences include at least one visual XR experience and at least one non-visual XR experience; and

presenting, with the computing system and using a user experience (“UX”) device, the generated one or more XR experiences.

2 . The method of claim 1 , wherein the computing system comprises at least one of a medical procedure computing system, a hub computing system, a three-dimensional (“3D”) graphical processing unit, a cluster computing system, a four-dimensional (“4D”) graphics computing system, a server computer, a cloud computing system, or a distributed computing system.

3 . The method of claim 1 , wherein the one or more devices comprise at least one of one or more catheters, one or more catheter interconnect cables, one or more valves, one or more balloons, one or more rigid robotic devices, one or more soft robotic devices, one or more stents, one or more needles, one or more occluders, one or more diagnostic catheters, one or more surgical tools, one or more monitoring devices, one or more cameras, one or more imaging tools, one or more fiducials, one or more staples, one or more anchors, one or more meshes, one or more vascular cannulae, one or more circulatory pumps, one or more valve repair devices, one or more embolic protection devices, one or more vascular closure tools, one or more septal closure tools, one or more ventricular closure tools, one or more lasers, one or more plaque removal tools, one or more guide wires, one or more introducers, one or more sheaths, one or more pillcams, one or more clips, one or more capsules, or one or more energy delivery tools.

4 . The method of claim 3 , wherein the one or more devices comprise at least one of one or more valves, one or more soft robotic devices, one or more stents, one or more surgical tools, one or more imaging tools, or one or more valve repair devices.

5 . The method of claim 1 , wherein the one or more imaging devices comprise at least one of a magnetic resonance imaging (“MRI”) system, a diffusion-tensor imaging (“DTI”) system, a computed tomography (“CT”) system, an ultrasound (“US”) system, a transesophageal echocardiography (“TEE”) system, an intra-cardiac echocardiography (“ICE”) system, a transthoracic echocardiography (“TTE”) system, an intravascular ultrasound (“IVUS”) system, an electromechanical wave imaging (“EWI”) system, a neuro-endoscopy system, a single photon emission computed tomography (“SPECT”) system, a magnetic resonance angiography (“MRA”) system, a computed tomography angiography (“CTA”) system, a blood oxygen-level dependent signal (“BOLD”) system, an arterial spin labeling (“ASL”) system, a magnetoencephalography (“MEG”) system, a positron emission tomography (“PET”) system, an electroencephalography (“EEG”) system, an optical coherence tomography (“OCT”) system, an optical imaging spectroscopy (“OIS”) system, a magnetic resonance spectroscopy (“MRS”) system, a dynamic susceptibility contrast (“DSC”) MRI system, a fluid-attenuated inversion recovery (“FLAIR”) system, a fluoroscopy system, an X-ray system, a 3D scanning system, an infrared (“IR”) system, an ultraviolet (“UV”) system, a bioluminescent system, an endoscopy system, a triboluminescence system, an image fusion system, or a microscope.

6 . The method of claim 5 , wherein the one or more imaging devices comprise at least one of a magnetic resonance imaging (“MRI”) system, a computed tomography (“CT”) system, an ultrasound (“US”) system, a transesophageal echocardiography (“TEE”) system, an intra-cardiac echocardiography (“ICE”) system, a transthoracic echocardiography (“TTE”) system, an intravascular ultrasound (“IVUS”) system, an electromechanical wave imaging (“EWI”) system, a fluoroscopy system, or a 3D scanning system.

7 . The method of claim 1 , wherein the cardiac blood flow procedure comprises at least one of a surgical procedure, a left atrial appendage (“LAA”) procedure, a transcatheter aortic valve repair (“TAVr”) procedure, a transcatheter aortic valve replacement (“TAVR”) procedure, a transcatheter mitral valve repair (“TMVr”) procedure, a transcatheter mitral valve replacement (“TMVR”) procedure, a transcatheter pulmonic valve repair (“TPVr”) procedure, a transcatheter pulmonic valve replacement (“TPVR”) procedure, a transcatheter tricuspid valve repair (“TTVr”) procedure, a transcatheter tricuspid valve replacement (“TTVR”) procedure, a coronary angioplasty procedure, a stenting procedure, a heart bypass procedure, a cardiac mapping procedure, an endovascular repair procedure, a minimally invasive endovascular repair procedure, a surgical heart valve repair and replacement procedure, a transcatheter pulmonary valve (“TPV”) therapy, a ventricular assist device (“VAD”) installation procedure, an intra-aortic balloon pump (“IABP”) implantation procedure, or a heart transplant operation.

8 . The method of claim 7 , wherein the cardiac blood flow procedure comprises at least one of a surgical procedure, a transcatheter aortic valve repair (“TAVr”) procedure, a transcatheter aortic valve replacement (“TAVR”) procedure, a transcatheter mitral valve repair (“TMVr”) procedure, a transcatheter mitral valve replacement (“TMVR”) procedure, a transcatheter pulmonic valve repair (“TPVr”) procedure, a transcatheter pulmonic valve replacement (“TPVR”) procedure, a transcatheter tricuspid valve repair (“TTVr”) procedure, a transcatheter tricuspid valve replacement (“TTVR”) procedure, a stenting procedure, a cardiac mapping procedure, an endovascular repair procedure, a minimally invasive endovascular repair procedure, a surgical heart valve repair and replacement procedure, a transcatheter pulmonary valve (“TPV”) therapy, or a ventricular assist device (“VAD”) installation procedure.

9 . The method of claim 1 , wherein the one or more XR experiences comprise at least one of one or more augmented reality (“AR”) images, one or more AR videos, one or more virtual reality (“VR”) images, one or more VR videos, one or more mixed reality (“MR”) images, or one or more MR videos.

10 . The method of claim 1 , wherein generating the one or more XR experiences comprises generating, with the computing system, the one or more XR experiences comprising at least three or more of one or more images, one or more sounds, one or more tactile responses, one or more simulated smells, or one or more simulated tastes, based at least in part on the mapping of the received one or more device data and the received one or more imaging data to the multi-dimensional representation of the one or more internal portions of the patient.

11 . The method of any of claim 1 , wherein the UX device comprises at least one of a headset, UX glasses, a viewing window, a microscope, a supplement to existing glasses, headphones, UX contact lenses, a heads-up display (“HUD”) device, a 3D spatial sound system, an olfactory simulation system, a taste simulation system, a telemonitoring system, a rigid robotic device control and sensory feedback system, a soft robotic device control and sensory feedback system, a control system for nanostructures, a control system for cells, a control system for genes, an eye control system, a voice control system, a remote control system, a gesture-based control system, a sign language-based control system, a body-part-based control system, a joystick, a mouse, a two-dimensional (“2D”) screen display, a 3D refractive display, a parallel reality system, a projection system, a nanoparticle reconstruction system, a fan-based display, a water-based display, an ionized air-based display, an ionized laser-based display, a smoke-based display, a sand-based display, a particulate-based display, a 3D printed reconstruction system, a sensory neuro-perception system, a sensory conversion system, a blow-based control system, a neuro-interface system, a peripheral nerve-computer interface system, a customized view generation system, a ghosting and prediction system, a master-slave control system, an annotation system, or a haptic feedback system.

12 . The method of claim 11 , wherein the UX device comprises at least one of a headset, UX glasses, a soft robotic device control and sensory feedback system, a two-dimensional (“2D”) screen display, a 3D refractive display, an annotation system, or a haptic feedback system.

13 . The method of claim 1 , further comprising:

receiving, with the computing system, one or more sensor data associated with one or more sensors configured to monitor at least one of biometric data, biological data, genetic data, cellular data, or procedure-related data of the patient; and

analyzing, with the computing system, the received one or more sensor data;

wherein mapping, with the computing system, the received one or more device data and the received one or more imaging data to the multi-dimensional representation of the one or more internal portions of the patient comprises mapping, with the computing system, two or more of the received one or more device data, the received one or more sensor data, or the received one or more imaging data to the multi-dimensional representation of the one or more internal portions of the patient, based at least in part on the analysis.

14 . The method of claim 13 , wherein generating the one or more XR experiences comprises:

combining, with the computing system, the received one or more device data, the received one or more sensor data, and the received one or more imaging data into the multi-dimensional representation, based at least in part on the analysis and mapping; and

generating, with the computing system, the one or more XR experiences based on the multi-dimensional representation.

15 . The method of claim 13 , wherein the one or more sensors comprise at least one of one or more chronically implanted sensors, one or more diagnostic sensors, one or more surgical sensors, one or more wearable sensors, one or more gas sensors, one or more optical sensors, one or more contactless optical sensors, one or more fiducial alignment sensors, one or more tool recognition sensors, one or more collision detection sensors, one or more room traffic flow sensors, one or more ultrasound sensors, one or more flow sensors, one or more blood velocity sensors, one or more blood volume sensors, one or more electrical sensors, one or more voltage sensors, one or more amperage sensors, one or more wattage sensors, one or more impedance sensors, one or more chemical sensors, one or more pH sensors, one or more motion sensors, one or more proximity sensors, one or more light sensors, one or more sound sensors, one or more laser sensors, one or more blood pressure sensors, one or more heart rate sensors, one or more pulse sensors, one or more respiratory rate sensors, one or more oxygen sensors, one or more carbon dioxide (“CO 2 ”) sensors, one or more hormonal sensors, one or more fluid levels, one or more doppler sensors, one or more biomarker sensors, one or more genetic sensors, one or more blood chemistry sensors, one or more tissue matrix sensors, one or more bacteria sensors, one or more respiration sensors, one or more mechanical sensors, one or more infrared (“IR”) sensors, one or more IR-based temperature sensors, one or more ultraviolet (“UV”) sensors, one or more digital image correlation (“DIC”) sensors, one or more cameras, one or more surgeon fatigue sensors, one or more IR-based temperature sensors, one or more moisture sensors, one or more perfusion sensors, one or more electromyography (“EMG”) sensors, one or more emotional stress sensors, one or more sleep sensors, one or more humidity sensors, one or more cardiac hemodynamics sensors, one or more ischemia sensors, one or more hematocrit (“HCT”) level sensors, one or more temperature sensors, one or more pressure sensors, one or more force sensors, one or more strain sensors, one or more stress sensors, one or more olfactory sensors, one or more tissue contractility sensors, one or more compliance sensors, one or more immobilized biocatalyst sensors, one or more enzyme sensors, one or more immunoglobulin sensors, one or more bacterial sensors, one or more mammalian tissue sensors, one or more plant tissue sensors, one or more cell sensors, one or more subcellular sensors, one or more specific peptide sensors, one or more specific protein sensors, one or more specific enzyme sensors, one or more specific gas sensors, one or more specific ion sensors, one or more metabolic process sensors, one or more viscosity sensors, one or more electromagnetic interference (“EMI”) sensors, one or more photographic plate sensors, one or more polymer-metal sensors, one or more charge coupled devices (“CCDs”), one or more photo diode arrays, one or more electrochemical sensors, one or more vibration sensors, one or more sound wave sensors, one or more magnetic sensors, one or more visible light sensors, one or more radiation sensors, one or more biometric sensors, one or more electroencephalographic (“EEG”) sensors, one or more brainwave sensors, or one or more pain sensors.

16 . The method of claim 15 , wherein the one or more sensors comprise at least one of one or more diagnostic sensors, one or more optical sensors, one or more contactless optical sensors, one or more ultrasound sensors, one or more motion sensors, one or more proximity sensors, one or more blood pressure sensors, one or more heart rate sensors, one or more respiratory rate sensors, one or more impedance sensors, one or more infrared (“IR”) sensors, one or more IR-based temperature sensors, one or more fiducial alignment sensors, one or more tool recognition sensors, one or more collision detection sensors, one or more room traffic flow sensors, one or more surgeon fatigue sensors, or one or more cognitive overload sensors.

17 . The method of claim 13 , wherein the generated one or more XR experiences are presented to provide one or more of: a guide for a medical professional, a navigation tool during the cardiac blood flow procedure, a proximity detection tool during the cardiac blood flow procedure, a three-dimensional (“3D”) or four-dimensional (“4D”) visualization view of the one or more internal portions of the patient, a heads-up display of the one or more device data, a heads-up display of biological data of the patient, a heads-up display of chemical data of the patient, a heads-up display of physiological data of the patient, or a heads-up display of procedure-related data of the patient.

18 . The method of claim 1 , further comprising:

tracking, with the computing system, the one or more devices, using at least one of an electropotential-based tracking system, an impedance-based tracking system, an electromagnetic-based tracking system, a magnetic anomaly detection-based tracking system, a radio frequency identification (“RFID”)-based tracking system, a Bluetooth-based tracking system, a wireless-based tracking system, an optical-based tracking system, a laser-based tracking system, an ultrasound (“US”) imaging-based tracking system, a computer vision-based tracking system, a fluoroscopy-based tracking system, an MRI-based tracking system, an accelerometer-based tracking system, a global positioning system (“GPS”)-based tracking system, an infrared (“IR”)-based tracking system, an ultrasonic sound-based tracking system, a piezoelectric-based tracking system, a simultaneous localization and mapping (“SLAM”)-based tracking system, an acoustic-based tracking system, a radar-based tracking system, a feature identification-based tracking system, a machine learning-based tracking system, a predictive tracking system, a prescriptive tracking system, or a near-field communications-based tracking system.

19 . The method of claim 18 , further comprising:

tracking, with the computing system, the one or more devices, using at least one of an impedance-based tracking system, an electromagnetic-based tracking system, a radio frequency identification (“RFID”)-based tracking system, an optical-based tracking system, an ultrasound (“US”) imaging-based tracking system, a computer vision-based tracking system, a fluoroscopy-based tracking system, an MRI-based tracking system, an accelerometer-based tracking system, a machine learning-based tracking system, a predictive tracking system, or a prescriptive tracking system.

20 . The method of claim 1 , wherein the one or more device data, associated with each of the one or more devices configured to perform the cardiac blood flow procedure, is received with the computer system while the one or more devices are positioned within a body of the patient.

21 . The method of claim 20 , wherein the one or more device data, associated with each of the one or more devices configured to perform the cardiac blood flow procedure, is received with the computer system while the one or more devices are positioned within the heart or a blood vessel of the patient.

22 . The method of claim 1 , wherein the one or more internal portions of the patient comprises one or more luminal portions of the patient.

23 . The method of claim 22 , wherein the one or more luminal portions of the patient are within the heart or a blood vessel of the patient.

24 . An apparatus operable to present patient information to a user, the apparatus comprising:

at least one processor; and

a non-transitory computer readable medium communicatively coupled to the at least one processor, the non-transitory computer readable medium having stored thereon computer software comprising a set of instructions that, when executed by the at least one processor, causes the apparatus to:

receive one or more device data associated with each of one or more devices configured to perform a cardiac blood flow procedure to provide effective blood flow through a heart and to or from blood vessels of a patient;

receive one or more imaging data associated with each of one or more imaging devices configured to generate images of one or more internal portions of the patient;

analyze the received one or more device data, the received one or more sensor data, and the received one or more imaging data;

map the received one or more device data and the received one or more imaging data to a multi-dimensional representation of the one or more internal portions of the patient, based at least in part on the analysis, wherein the multi-dimensional representation comprises data corresponding to three dimensions, four dimensions, or more than four dimensions;

generate one or more XR experiences, based at least in part on the mapping, wherein the one or more XR experiences include at least one visual XR experience and at least one non-visual XR experience; and

present, using a user experience (“UX”) device, the generated XR experiences.

25 . A system operable to present patient information to a user, the system comprising:

one or more devices configured to perform a cardiac blood flow procedure to provide effective blood flow through a heart and to or from blood vessels of a patient;

one or more imaging devices configured to generate images of one or more internal portions of the patient;

a computing system, comprising:

at least one first processor; and

a first non-transitory computer readable medium communicatively coupled to the at least one first processor, the first non-transitory computer readable medium having stored thereon computer software comprising a first set of instructions that, when executed by the at least one first processor, causes the computing system to:

receive one or more device data associated with each of the one or more devices;

receive one or more imaging data associated with each of the one or more imaging devices;

analyze the received one or more device data and the received one or more imaging data;

map the received one or more device data and the received one or more imaging data to a multi-dimensional representation of the one or more internal portions of the patient, based at least in part on the analysis, wherein the multi-dimensional representation comprises data corresponding to three dimensions, four dimensions, or more than four dimensions;

generate one or more XR experiences, based at least in part on the mapping, wherein the one or more XR experiences include at least one visual XR experience and at least one non-visual XR experience; and

send the generated one or more XR experiences to a user experience (“UX”) device; and

the UX device, comprising:

at least one second processor; and

a second non-transitory computer readable medium communicatively coupled to the at least one second processor, the second non-transitory computer readable medium having stored thereon computer software comprising a second set of instructions that, when executed by the at least one second processor, causes the UX device to:

receive the generated one or more XR experiences; and

present the received one or more XR experiences to the user.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2023
From: BRAIDO, PETER N.; TAKAYAMA, SHINICHI JOSEPH
To: MEDTRONIC, INC.
Reel/Frame 065253/0789 →
Continuity (5)
Provisional Application 63058632 · Jul 30, 2020
Provisional Application 63032278 · May 29, 2020
Provisional Application 63032289 · May 29, 2020
Provisional Application 63032283 · May 29, 2020
Related Publication 20230317248A1 · Oct 5, 2023
References Cited (149)
US 7187964B2 · Khoury · 2007 [cited by applicant]
US 7892165B2 · Nakamura · 2011 [cited by applicant]
US 7998095B2 · McAuley · 2011 [cited by applicant]
US 8460282B2 · McAuley · 2013 [cited by applicant]
US 8482859B2 · Border et al. · 2013 [cited by applicant]
US 8768022B2 · Miga et al. · 2014 [cited by applicant]
US 8792693B2 · Satish et al. · 2014 [cited by applicant]
US 8902254B1 · Laughlin et al. · 2014 [cited by applicant]
US 9128281B2 · Osterhout et al. · 2015 [cited by applicant]
US 9134534B2 · Border et al. · 2015 [cited by applicant]
US 9223134B2 · Miller et al. · 2015 [cited by applicant]
US 9232982B2 · Soler et al. · 2016 [cited by applicant]
US 9298884B1 · Ahmad · 2016 [cited by applicant]
US 9317743B2 · Datta et al. · 2016 [cited by applicant]
US 9452294B2 · Kaula et al. · 2016 [cited by applicant]
US 9492241B2 · Joskowicz et al. · 2016 [cited by applicant]
US 9526443B1 · Berme et al. · 2016 [cited by applicant]
US 9615788B2 · Kaula et al. · 2017 [cited by applicant]
US 9639953B2 · Moraviec · 2017 [cited by applicant]
US 9642606B2 · Charles et al. · 2017 [cited by applicant]
US 9659104B2 · Soon-Shiong et al. · 2017 [cited by applicant]
US 9687301B2 · Lee et al. · 2017 [cited by applicant]
US 9720505B2 · Gribetz et al. · 2017 [cited by applicant]
US 9740296B2 · Cohen et al. · 2017 [cited by applicant]
US 9767608B2 · Lee et al. · 2017 [cited by applicant]
US 9773312B2 · Lee · 2017 [cited by applicant]
US 9855103B2 · Tsekos et al. · 2018 [cited by applicant]
US 9866767B2 · Jones · 2018 [cited by applicant]
US 9870060B2 · Marggraff et al. · 2018 [cited by applicant]
US 9875540B2 · Blumhofer et al. · 2018 [cited by applicant]
US 9888973B2 · Olson et al. · 2018 [cited by applicant]
US 9911225B2 · Engel et al. · 2018 [cited by applicant]
US 9928588B2 · Vilsmeier · 2018 [cited by applicant]
US 9947104B2 · Seiler et al. · 2018 [cited by applicant]
US 9986983B2 · Weingarten et al. · 2018 [cited by applicant]
US 10026227B2 · Laughlin et al. · 2018 [cited by applicant]
US 10152796B2 · Guo et al. · 2018 [cited by applicant]
US 10180572B2 · Osterhout et al. · 2019 [cited by applicant]
US 10665337B2 · Schulhauser et al. · 2020 [cited by applicant]
US 11005661B1 · Neumann · 2021 [cited by applicant]
US 11037679B1 · Neumann · 2021 [cited by applicant]
US 11207133B1 · Douglas et al. · 2021 [cited by applicant]
US 11217033B1 · Morgan et al. · 2022 [cited by applicant]
US 11270789B1 · Neumann · 2022 [cited by applicant]
US 12070362B2 · Braido et al. · 2024 [cited by applicant]
US 12193888B2 · Braido · 2025 [cited by examiner]
US 12220176B2 · Calloway · 2025 [cited by examiner]
US 20020198891A1 · Li et al. · 2002 [cited by applicant]
US 20070173861A1 · Strommer et al. · 2007 [cited by applicant]
US 20080033527A1 · Nunez et al. · 2008 [cited by applicant]
US 20100198346A1 · Keogh et al. · 2010 [cited by applicant]
US 20120188352A1 · Wittenberg et al. · 2012 [cited by applicant]
US 20130035757A1 · Zentgraf et al. · 2013 [cited by applicant]
US 20140128726A1 · Quill et al. · 2014 [cited by applicant]
US 20140176661A1 · Smurro et al. · 2014 [cited by applicant]
US 20140296704A1 · Alves et al. · 2014 [cited by applicant]
US 20150037201A1 · Armour et al. · 2015 [cited by applicant]
US 20160019716A1 · Huang et al. · 2016 [cited by applicant]
US 20160085774A1 · Bhamidipati et al. · 2016 [cited by applicant]
US 20160157798A1 · Anderson · 2016 [cited by applicant]
US 20160350303A1 · Fischer et al. · 2016 [cited by applicant]
US 20170021132A1 · Laby et al. · 2017 [cited by applicant]
US 20170098333A1 · Varga · 2017 [cited by applicant]
US 20170103581A1 · Mullins et al. · 2017 [cited by applicant]
US 20170109484A1 · Herger et al. · 2017 [cited by applicant]
US 20170206419A1 · Mullins · 2017 [cited by applicant]
US 20170221387A1 · Lampotang et al. · 2017 [cited by applicant]
US 20170258526A1 · Lang · 2017 [cited by applicant]
US 20170258586A1 · Bateman et al. · 2017 [cited by applicant]
US 20170293805A1 · Kontschieder et al. · 2017 [cited by applicant]
US 20170323148A1 · Sarkar et al. · 2017 [cited by applicant]
US 20170340396A1 · Romo et al. · 2017 [cited by applicant]
US 20170367771A1 · Tako et al. · 2017 [cited by applicant]
US 20180012416A1 · Jones et al. · 2018 [cited by applicant]
US 20180350010A1 · Kuper et al. · 2018 [cited by applicant]
US 20190183576A1 · Fahim · 2019 [cited by examiner]
US 20190183577A1 · Fahim et al. · 2019 [cited by applicant]
US 20190262617A1 · Ghosh · 2019 [cited by applicant]
US 20190298450A1 · Dasi et al. · 2019 [cited by applicant]
US 20190307516A1 · Schotzko et al. · 2019 [cited by applicant]
US 20190350671A1 · Varshney et al. · 2019 [cited by applicant]
US 20190362556A1 · Ben-Dor et al. · 2019 [cited by applicant]
US 20190384764A1 · Taylor · 2019 [cited by applicant]
US 20200060765A1 · Fahim et al. · 2020 [cited by applicant]
US 20200121898A1 · Christopher et al. · 2020 [cited by applicant]
US 20200129136A1 · Harding et al. · 2020 [cited by applicant]
US 20200138518A1 · Lang · 2020 [cited by applicant]
US 20200151874A1 · Peterson et al. · 2020 [cited by applicant]
US 20200321123A1 · Neumann · 2020 [cited by applicant]
US 20200323516A1 · El Kaffas et al. · 2020 [cited by applicant]
US 20200391016A1 · Passman et al. · 2020 [cited by applicant]
US 20210052348A1 · Schwägli et al. · 2021 [cited by applicant]
US 20210137634A1 · Lang · 2021 [cited by applicant]
US 20210192759A1 · Lang · 2021 [cited by applicant]
US 20210287783A1 · Jhaveri · 2021 [cited by applicant]
US 20210369393A1 · Braido et al. · 2021 [cited by applicant]
US 20210369394A1 · Braido et al. · 2021 [cited by applicant]
US 20220029986A1 · Neumann · 2022 [cited by applicant]
US 20220167929A1 · Neumann · 2022 [cited by applicant]
US 20220361954A1 · Braido et al. · 2022 [cited by applicant]
US 20230008264A1 · Mangual-Soto et al. · 2023 [cited by applicant]
US 20230057317A1 · Kadidal et al. · 2023 [cited by applicant]
US 20230143522A1 · Keast · 2023 [cited by applicant]
US 20230157757A1 · Braido et al. · 2023 [cited by applicant]
US 20230157762A1 · Braido et al. · 2023 [cited by applicant]
US 20230230321A1 · Schreckenberg et al. · 2023 [cited by applicant]
US 20230309832A1 · Braido et al. · 2023 [cited by applicant]
JP 2019109739A · 2019 [cited by applicant]
WO 0120552A1 · 2001 [cited by applicant]
WO 2009148317A1 · 2009 [cited by applicant]
WO 2021243310A1 · 2021 [cited by applicant]
WO 2021243311A1 · 2021 [cited by applicant]
WO 2021243313A1 · 2021 [cited by applicant]
WO 2021243314A1 · 2021 [cited by applicant]
Gloud M.K., et al., “Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?,” Diagnosis and Management of Lung Cancer, 3rd Ed: Accp Guidelines, Chest, 2013, vol. 143 (5 Suppl), pp. 1-28. [cited by applicant]
Li C., et al., “Augmented Reality Navigation-guided Pulmonary Nodule Localization in a Canine Model,” Translational Lung Cancer Research, Nov. 2021, vol. 10 (11), pp. 4152-4160. [cited by applicant]
U.S. Final Office Action dated Oct. 16, 2024 in U.S. Appl. No. 17/974,689. [cited by applicant]
U.S. Non-Final Office Action dated May 2, 2024 in U.S. Appl. No. 17/974,689. [cited by applicant]
Azizian M., et al., “Intraoperative 3d Stereo Visualization for Image-guided Cardiac Ablation,” Medical Imaging 2011: Visualization, Image-guided Procedures, and Modeling, SPIE, Mar. 2, 2011, vol. 7964, No. 1, 8 pages. [cited by applicant]
International Preliminary Report on Patentability dated Dec. 8, 2022, in PCT Application No. PCT/US2021/035037. [cited by applicant]
International Preliminary Report on Patentability dated Dec. 8, 2022, in PCT Application PCT/US2021/035036. [cited by applicant]
International Search Report & Written Opinion dated Sep. 14, 2021, in Application No. PCT/US2021/035033. [cited by applicant]
International Search Report & Written Opinion dated Sep. 16, 2021, in Application No. PCT/US2021/035034. [cited by applicant]
International Search Report and Written Opinion dated in Application No. Sep. 16, 2021 PCT/US2021/035037. [cited by applicant]
International Search Report and Written Opinion dated Oct. 4, 2021, in Application No. PCT/US2021/037655. [cited by applicant]
International Search Report and Written Opinion dated Sep. 16, 2021 in Application No. PCT/US2021/035036. [cited by applicant]
Linte, C.A., et al., “Inside the Beating Heart: An in Vivo Feasibility Study on Fusing Pre- and Intra-Operative Imaging for Minimally Invasive Therapy”, International Journal of Computer Assisted Radiology and Surgery [… [cited by applicant]
Linte, C.A., et al., “Virtual and Augmented Medical Imaging Environments: Enabling Technology for Minimally Invasive Cardiac Interventional Guidance”, IEEE Reviews in Biomedical Engineering, 2010, vol. 3, pp. 25-47. [cited by applicant]
Robb, A., “Using Patient Specific Anatomic Models”, IEEE Engineering in Medicine and Biology Magazine, IEEE Service Center, Pisacataway, 1996, vol. 15, No. 2, pp. 60-69. [cited by applicant]
Silva., et al., Medical Imaging archiving: A comparison between several NoSQL solutions, IEEE EMBS International Conference on Information Technology Applications in Biomedicine (ITAB), 5 pages. [cited by applicant]
Suematsu, Y., et al., “Robotic-Assisted Closure of Atrial Septal Defect Under Real-Time Three-Dimensional Echo Guide: In Vitro Study”, European Journal of Cardio-Thoracic Surgery, Springer Verlag, Beriln, 2007, vol. 32,… [cited by applicant]
Zhang, Q., et al., “Dynamic Real-Time 4D Cardiac MDCT Image Display using GPU-Accelerated Volume Rendering”, Computerized Medical Imaging and Graphics, Pergamon Press, 2009, vol. 33, No. 6, pp. 461-476. [cited by applicant]
Doughty, M., et al., “Surgeonassist-net: Towards Contextaware Head-mounted Display-based Augmented Reality for Surgical Guidance”, 16th European Conference—Computer Vision—ECCV 2020, pp. 667-677. [cited by applicant]
Goo H.W., et al., “Advanced Medical Use of Three-dimensional Imaging in Congenital Heart Disease: Augmented Reality, Mixed Reality, Virtual Reality, and Three-dimensional Printing,” Korean Journal of Radiology, 2020, vo… [cited by applicant]
Gu, M. et al., “Permanent His Bundle Pacing Implantation Facilitated by Visualization of the Tricuspid Valve Annulus,” Circulation. Arrhythmia and electrophysiology, Oct. 2020, vol. 13, No. 10, 11 Pages. [cited by applicant]
International Search Report and Written Opinion dated Jan. 27, 2023 in PCT Application No. PCT/IB2022/060244. [cited by applicant]
Lin, J. et al., “Bilateral Bundle Branch Area Pacing to Achieve Physiological Conduction System Activation,” Circulation. Arrhythmia and electrophysiology, Aug. 2020, vol. 13, No. 8, 11 pages. [cited by applicant]
Liu, X., et al., “Contrast-enhanced Image Guided Lead Deployment for Left Bundle Branch Pacing,” Heart Rhythm, Aug. 2021, vol. 18, No. 8, pp. 1318-1325. [cited by applicant]
Maier-Hein, L., et al., “Surgical Data Science—From Concepts Toward Clinical Translation,” Arxiv.Org, Cornell University Library, 201 Olin Library Cornell University Ithaca, NY 14853, Jul. 30, 2021. [cited by applicant]
U.S. Non-Final Office Action dated Aug. 19, 2024 in U.S. Appl. No. 17/700,622. [cited by applicant]
U.S. Non-Final Office Action dated Dec. 14, 2023 in U.S. Appl. No. 17/334,487. [cited by applicant]
U.S. Non-Final Office Action dated Sep. 10, 2024 in U.S. Appl. No. 17/955,941. [cited by applicant]
U.S. Notice of Allowance dated Apr. 17, 2024 in U.S. Appl. No. 17/334,487. [cited by applicant]
U.S. Restriction requirement dated Jun. 20, 2024, in U.S. Appl. No. 17/955,941. [cited by applicant]
U.S. Advisory Action dated May 29, 2025 in U.S. Appl. No. 17/955,941. [cited by applicant]
U.S. Final Office Action dated Dec. 9, 2024 in U.S. Appl. No. 17/700,622. [cited by applicant]
U.S. Final Office Action dated Mar. 18, 2025 in U.S. Appl. No. 17/955,941. [cited by applicant]
U.S. Non-Final Office Action dated Mar. 11, 2025 in U.S. Appl. No. 17/999,986. [cited by applicant]
US Non-Final Office Action dated May 21, 2025 in U.S. Appl. No. 17/700,622. [cited by applicant]